Session Information
Date: Monday, June 20, 2016
Session Title: Surgical therapy: Parkinson's disease
Session Time: 12:30pm-2:00pm
Location: Exhibit Hall located in Hall B, Level 2
Objective: Our aim was to assess the changes in quality of life after bilateral subthalamic stimulation in our patients with Parkinson’s disease and to analyze its clinical associations.
Background: In the Neuromodulation Centre in Budapest, we have performed 59 DBS implantations in movement disorders since 2009. Thirty-four patients have been operated with Parkinson’s disease (PD).
Methods: Twenty-eight patients with Parkinson’s disease (18 females, 10 males), who had a follow-up visit one year after the operation, were enrolled in the study. Each patient underwent a bilateral DBS lead and pulse generator implantation simultaneously. Electrophysiological mapping was executed with five microelectrodes; clinical symptoms were controlled through macrostimulation. Clinical characteristics were measured by the Unified Parkinson’s disease Rating Scale (UPDRS), the 39-item Parkinson’s disease Questionnaire (PDQ-39) the Schwab-England Activities of Daily Living Scale and the Beck Depression Inventory (BDI). For statistical analysis, we used the Wilcoxon signed-rank test and the Spearman’s rank correlation.
Results: At the time of operation, the mean age of the patients was 60±8.8 years (mean±standard deviation) with the disease duration of 12±5.3 years. The measured scores have changed with subthalamic stimulation as follows [pre-/postoperative; median (interquartile range)]: the UPDRS total scores: 63(42)/21(5), p<0.001; the Schwab-England scores: 60(30)/80(20), p<0.001; the BDI scores: 8(8)/9(9.5), p=0.46; the PDQ-39 total scores: 29(13.4)/23.45(15.10), p=0.002. There was a significant improvement in every PDQ-39 item except the Emotional Well-being, the Communication and the Stigma. The postoperative PDQ-39 total score correlated with disease duration at the time of operation (r= -0.434 p=0.04) and with the postoperative scores of the UPDRS I (r=0.434, p=0.04), the UPDRS IV (r=0.67 p=0.001), the Schwab-England scale (r=-0.6 p=0.003) and the BDI (r=0.595, p=0.006).
Conclusions: The health-related quality of life significantly improved after operation; which was significantly related to the disease duration at the time of operation, the postoperative cognitive function, the mood and the motor fluctuations in our patients. There was a significant development in all of the PDQ-39 items, except for the Emotional Well-being, the Communication and the Stigma.
To cite this abstract in AMA style:
A. Kelemen, L. Eröss, D. Albert, I. Rózsa, E. Csibri, L. Entz, D. Fabó, L. Halász, G. Rudas, P. Barsi, P. Golopencza, G. Tamás. Efficacy of the bilateral subthalamic stimulation in Parkinson’s disease, results from the Neuromodulation Centre in Budapest [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/efficacy-of-the-bilateral-subthalamic-stimulation-in-parkinsons-disease-results-from-the-neuromodulation-centre-in-budapest/. Accessed November 22, 2024.« Back to 2016 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/efficacy-of-the-bilateral-subthalamic-stimulation-in-parkinsons-disease-results-from-the-neuromodulation-centre-in-budapest/